Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,180 | 73 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $487.30 | 31 | $0 (2024) |
| PFIZER INC. | $292.53 | 17 | $0 (2021) |
| Novo Nordisk Inc | $61.53 | 4 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $39.56 | 2 | $0 (2019) |
| ABBVIE INC. | $38.15 | 2 | $0 (2024) |
| Lilly USA, LLC | $33.42 | 2 | $0 (2023) |
| Merck Sharp & Dohme Corporation | $27.19 | 2 | $0 (2017) |
| Jazz Pharmaceuticals Inc. | $19.82 | 1 | $0 (2018) |
| Otsuka America Pharmaceutical, Inc. | $19.48 | 1 | $0 (2018) |
| Amarin Pharma Inc. | $17.88 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $63.56 | 3 | ABBVIE INC. ($22.17) |
| 2023 | $55.20 | 3 | Janssen Pharmaceuticals, Inc ($36.13) |
| 2022 | $137.51 | 8 | Janssen Pharmaceuticals, Inc ($75.60) |
| 2021 | $245.99 | 15 | PFIZER INC. ($118.50) |
| 2020 | $66.07 | 4 | PFIZER INC. ($52.20) |
| 2019 | $306.48 | 21 | Janssen Pharmaceuticals, Inc ($109.90) |
| 2018 | $232.65 | 14 | Janssen Pharmaceuticals, Inc ($113.99) |
| 2017 | $72.59 | 5 | Merck Sharp & Dohme Corporation ($27.19) |
All Payment Transactions
73 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/12/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: VIROLOGY | ||||||
| 04/13/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $21.95 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/21/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: Diabetes | ||||||
| 12/15/2023 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: Obesity | ||||||
| 11/03/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/17/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/20/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/09/2022 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: Sickle Cell Disease | ||||||
| 05/13/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: Diabetes | ||||||
| 04/28/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $25.84 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/08/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: NEUROSCIENCE | ||||||
| 03/18/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $12.54 | General |
| Category: Obesity | ||||||
| 02/11/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/13/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/09/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/19/2021 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/04/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/15/2021 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/16/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/10/2021 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $17.83 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/19/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/13/2021 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/09/2021 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/24/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/04/2021 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 130 | 206 | $37,564 | $15,903 |
| 2022 | 4 | 66 | 115 | $15,077 | $6,039 |
| 2021 | 6 | 109 | 184 | $26,463 | $12,160 |
| 2020 | 4 | 78 | 97 | $11,174 | $5,206 |
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 28 | 65 | $12,740 | $5,759 | 45.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 26 | 57 | $7,809 | $3,364 | 43.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 48 | 52 | $7,540 | $3,066 | 40.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 15 | 19 | $6,992 | $2,459 | 35.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 13 | 13 | $2,483 | $1,256 | 50.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 25 | 73 | $10,001 | $3,873 | 38.7% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 11 | 11 | $2,101 | $1,106 | 52.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 19 | 19 | $2,755 | $1,019 | 37.0% |
| 81002 | Urinalysis, manual test | Office | 2022 | 11 | 12 | $220.00 | $41.29 | 18.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 23 | 72 | $12,024 | $5,556 | 46.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 26 | 50 | $5,400 | $2,612 | 48.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 15 | 15 | $4,230 | $2,247 | 53.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 18 | 18 | $2,376 | $980.82 | 41.3% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 13 | 13 | $2,145 | $708.37 | 33.0% |
| 81002 | Urinalysis, manual test | Office | 2021 | 14 | 16 | $288.00 | $55.68 | 19.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 24 | 39 | $4,212 | $2,117 | 50.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 30 | 31 | $4,092 | $1,757 | 42.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 13 | 16 | $2,672 | $1,295 | 48.4% |
| 81002 | Urinalysis, manual test | Office | 2020 | 11 | 11 | $198.00 | $37.86 | 19.1% |
About Dr. Kenneth Kigorwe, M.D
Dr. Kenneth Kigorwe, M.D is a Family Medicine healthcare provider based in Logansport, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/05/2008. The National Provider Identifier (NPI) number assigned to this provider is 1831355270.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kenneth Kigorwe, M.D has received a total of $1,180 in payments from pharmaceutical and medical device companies, with $63.56 received in 2024. These payments were reported across 73 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($1,180).
As a Medicare-enrolled provider, Kigorwe has provided services to 383 Medicare beneficiaries, totaling 602 services with total Medicare billing of $39,309. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Logansport, IN
- Active Since 08/05/2008
- Last Updated 07/26/2011
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1831355270
Products in Payments
- XARELTO (Drug) $478.25
- ELIQUIS (Drug) $258.08
- ENTRESTO (Drug) $39.56
- Rybelsus (Drug) $37.14
- CHANTIX (Drug) $34.45
- PNEUMOVAX 23 (Biological) $27.19
- MAVYRET (Drug) $22.17
- Xyrem (Drug) $19.82
- SAMSCA (Drug) $19.48
- ZEPBOUND (Drug) $19.07
- Vascepa (Drug) $17.88
- LEXISCAN (Drug) $17.08
- VIBERZI (Drug) $16.78
- Horizant (Drug) $16.06
- VRAYLAR (Drug) $15.98
- OXBRYTA (Drug) $15.69
- EVENITY (Biological) $15.29
- JARDIANCE (Drug) $14.35
- SHINGRIX (Biological) $14.29
- Vivitrol 380 mg (Drug) $14.27
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Logansport
Rafael Cruz, M.d, M.D
Family Medicine — Payments: $603.97
Cory Neumann, M.d, M.D
Family Medicine — Payments: $389.66
Dr. Robert Mckissick, M.d, M.D
Family Medicine — Payments: $250.24
Stephanie Dill, Np, NP
Family Medicine — Payments: $175.58
Olusina Akande, Md, Mba, MD, MBA
Family Medicine — Payments: $95.46
Dr. Dallis Bowditch, M.d, M.D
Family Medicine — Payments: $38.88